Literature DB >> 26100210

Treatment with a neutralising anti-rat interleukin-17 antibody after multiple-trauma reduces lung inflammation.

Heling Dai1, Li Xu2, Yu Tang3, Zhi Liu3, Tiansheng Sun4.   

Abstract

BACKGROUND: It has been well recognised that a deficit of numbers and function of CD4(+)CD25(+)Foxp3(+) cells (Treg) is attributed to the development of autoimmune diseases and inflammatory diseases; additionally, IL-17-producing cells (Th17) have a pro-inflammatory role. The balance between Th17 and Treg may be essential for maintaining immune homeostasis and has long been thought as one of the important factors in the development/prevention of autoimmune diseases and inflammatory diseases. In our previous research, we explored that cytokines (IL-17) and the balance of Treg/Th17 had a significant relevance with tissue (lung) inflammation and injury in acute-phase after multiple-trauma.
OBJECTIVE: To more verify whether an imbalance of Treg/Th17 is characteristic of rats suffering from multiple trauma. METHODS AND SUBJECTIVE: Using IL-17 monoclonal antibody (IL-17mAb)-treated multiple-trauma rat, we tested the pathogenic role of IL-17 in the development of multiple-trauma. Rat models were treated respectively with IL-17mAb or rat IgG 2A isotype control or phosphate-buffered solution after model was established. Normal rats only received anaesthesia and cannulation were taken as sham. Rats in each group were killed respectively at the end of 1h, 4h, 8h after injection. Collected serum and lung samples for assessment dynamically of MPO, IL-17, IL-6, and TGF-β-mRNA, and cytokine (IL-17, IL-6, TGF-β) and lung tissue for pulmonary histological analysis.
RESULTS: Neutralisation of IL-17 with anti-IL-17 can decrease serum IL-17 level and the IL-17-mRNA transcript level in lung, and ameliorate tissue inflammatory, defer disease course.
CONCLUSION: Our data suggest that IL-17 is crucially involved in the pathogenesis of multiple-trauma in rat, IL-17 inhibition might ameliorate the lung inflammation in acute-phase after multiple-trauma.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  IL-17; IL-17mAb; Lung; Multiple trauma

Mesh:

Substances:

Year:  2015        PMID: 26100210     DOI: 10.1016/j.injury.2015.05.016

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  5 in total

1.  Toll Like Receptor 4 Mediated Lymphocyte Imbalance Induces Nec-Induced Lung Injury.

Authors:  Hongpeng Jia; Chhinder P Sodhi; Yukihiro Yamaguchi; Peng Lu; Mitchell R Ladd; Adam Werts; William B Fulton; Sanxia Wang; Thomas Prindle; David J Hackam
Journal:  Shock       Date:  2019-08       Impact factor: 3.454

2.  Impacts of Interleukin-17 Neutralization on the Inflammatory Response in a Healing Ligament.

Authors:  Anna Eb Clements; Connie S Chamberlain; Ellen M Leiferman; William L Murphy; Ray Vanderby
Journal:  J Cytokine Biol       Date:  2017-04-06

3.  IL-17A promotes the proliferation of human nasopharyngeal carcinoma cells through p300-mediated Akt1 acetylation.

Authors:  Kemin Cai; Bing Wang; Hongmei Dou; Ronglan Luan; Xueli Bao; Jiusheng Chu
Journal:  Oncol Lett       Date:  2017-03-31       Impact factor: 2.967

4.  Trauma Induces Interleukin-17A Expression on Th17 Cells and CD4+ Regulatory T Cells as Well as Platelet Dysfunction.

Authors:  Friederike Hefele; Alexander Ditsch; Niels Krysiak; Charles C Caldwell; Peter Biberthaler; Martijn van Griensven; Stefan Huber-Wagner; Marc Hanschen
Journal:  Front Immunol       Date:  2019-10-11       Impact factor: 7.561

Review 5.  Regulatory T Cells and Acute Lung Injury: Cytokines, Uncontrolled Inflammation, and Therapeutic Implications.

Authors:  Shihui Lin; Hua Wu; Chuanjiang Wang; Zhibo Xiao; Fang Xu
Journal:  Front Immunol       Date:  2018-07-09       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.